T1	p 94 135	non-insulin dependent diabetes mellitus .
T2	p 255 316	30 non-insulin dependent ( Type II ) diabetic subjects during
T3	p 383 394	a metabolic
T4	p 1219 1237	Type II diabetes .
T5	p 1335 1362	Type II diabetic patients .
T6	i 14 54	angiotensin-converting enzyme inhibitors
T7	i 64 80	antihypertensive
T8	i 150 171	captopril monotherapy
T9	i 227 245	placebo-controlled
T10	i 347 379	run-in/drug ; placebo/wash-out )
T11	i 400 411	. Captopril
T12	i 626 640	ACE-inhibition
T13	i 1206 1215	captopril
T14	i 1236 1252	. ACE inhibitors
T15	i 1302 1331	antihypertensive intervention
T16	o 175 204	blood pressure and metabolism
T17	o 434 476	both systolic and diastolic blood pressure
T18	o 534 546	side effects
T19	o 561 602	postprandial blood glucose concentrations
T20	o 765 791	blood kinin concentrations
T21	o 890 1006	Body mass index , fasting plasma insulin , serum electrolyte pattern , uric acid , white blood count , lipid profile
T22	o 1018 1055	hepatic and renal function parameters